van Mulligen, E <br/><br/>
The impact of a disease flare during tapering of DMARDs on the lives of rheumatoid arthritis patients.  [electronic resource] 

 -  Seminars in arthritis and rheumatism  06 2020 
 - 423-431 p.  digital 
<br/><br/> Publication Type: Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1532-866X 
<br/><br/><label>Standard No.: </label>10.1016/j.semarthrit.2020.02.011  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aged<br/>Antirheumatic Agents--administration & dosage<br/>Arthritis, Rheumatoid--drug therapy<br/>Dose-Response Relationship, Drug<br/>Drug Tapering--methods<br/>Female<br/>Humans<br/>Male<br/>Middle Aged<br/>Minimal Clinically Important Difference<br/>Patient Reported Outcome Measures<br/>Physical Functional Performance<br/>Quality of Life<br/>Symptom Flare Up<br/>Time Factors<br/>Tumor Necrosis Factor Inhibitors--administration & dosage